Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women

Ather Mansoor, Keri Althoff, Stephen J Gange, Kathryn Anastos, Jack Dehovitz, Howard Minkoff, Robert Kaplan, Susan Holman, Jason M. Lazar

Research output: Contribution to journalArticle

Abstract

HIV infection is associated with left ventricular (LV) dysfunction and accelerated atherosclerosis. These conditions result in elevation of plasma natriuretic peptide (NP) levels. The present study compares N-terminal-pro-BNP (NT-pro-BNP) levels in HIV-infected and -uninfected women and identifies factors influencing NT-pro-BNP levels in HIV-infected women. A total of 454 HIV-infected and 200 HIV-uninfected participants from the Women's Interagency HIV Study (WIHS) had NT-pro-BNP determination. Elevated NT-pro-BNP level was defined using previously determined age stratified cut-off values of > 164 ng/liter (age 225 (age ≥ 60 years). HIV-infected women were older (41.6 ± 8.9 vs. 38.9±10.5 years, p <0.01) and were more likely to have anemia, hepatitis C virus (HCV) antibodies, and kidney dysfunction than HIV-uninfected women. HIV-infected women had significantly higher NT-pro-BNP levels (142.4 ± 524.8 vs. 73.6 ± 115.1 ng/liter, p = 0.01) and a higher prevalence of elevated NT-pro-BNP (12.1% vs. 7.5%; p= 0.08). In univariate analyses, elevated NT-pro-BNP was significantly associated with age, systolic BP, hypertension, anemia, triglyceride levels, kidney disease, and HCV seropositivity, but not HIV infection. In multivariate analysis, elevated NT-pro-BNP levels were significantly associated with anemia and kidney function, and had a borderline association with the presence of HCV antibodies. Among HIV-infected women, NT-pro-BNP levels were not independently associated with measures of severity of infection or with HAART use. Although HIV-infected women have higher NT-pro-BNP levels than HIV-uninfected women, the differences are due to non-HIV factors such as anemia, kidney disease, and HCV coinfection. These findings suggest that natriuretic peptide levels are a global marker of comorbidity in the setting of HIV infection.

Original languageEnglish (US)
Pages (from-to)997-1004
Number of pages8
JournalAIDS Research and Human Retroviruses
Volume25
Issue number10
DOIs
StatePublished - Oct 1 2009

Fingerprint

Comorbidity
HIV
Anemia
HIV Infections
Natriuretic Peptides
Hepatitis C Antibodies
Kidney Diseases
Hepacivirus
pro-brain natriuretic peptide (1-76)
Kidney
Highly Active Antiretroviral Therapy
Left Ventricular Dysfunction
Coinfection
Atherosclerosis
Triglycerides
Multivariate Analysis
Hypertension
Infection

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Cite this

Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women. / Mansoor, Ather; Althoff, Keri; Gange, Stephen J; Anastos, Kathryn; Dehovitz, Jack; Minkoff, Howard; Kaplan, Robert; Holman, Susan; Lazar, Jason M.

In: AIDS Research and Human Retroviruses, Vol. 25, No. 10, 01.10.2009, p. 997-1004.

Research output: Contribution to journalArticle

Mansoor, A, Althoff, K, Gange, SJ, Anastos, K, Dehovitz, J, Minkoff, H, Kaplan, R, Holman, S & Lazar, JM 2009, 'Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women', AIDS Research and Human Retroviruses, vol. 25, no. 10, pp. 997-1004. https://doi.org/10.1089/aid.2009.0038
Mansoor, Ather ; Althoff, Keri ; Gange, Stephen J ; Anastos, Kathryn ; Dehovitz, Jack ; Minkoff, Howard ; Kaplan, Robert ; Holman, Susan ; Lazar, Jason M. / Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women. In: AIDS Research and Human Retroviruses. 2009 ; Vol. 25, No. 10. pp. 997-1004.
@article{3727062f7af4406b9b87e0cda9dc0822,
title = "Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women",
abstract = "HIV infection is associated with left ventricular (LV) dysfunction and accelerated atherosclerosis. These conditions result in elevation of plasma natriuretic peptide (NP) levels. The present study compares N-terminal-pro-BNP (NT-pro-BNP) levels in HIV-infected and -uninfected women and identifies factors influencing NT-pro-BNP levels in HIV-infected women. A total of 454 HIV-infected and 200 HIV-uninfected participants from the Women's Interagency HIV Study (WIHS) had NT-pro-BNP determination. Elevated NT-pro-BNP level was defined using previously determined age stratified cut-off values of > 164 ng/liter (age 225 (age ≥ 60 years). HIV-infected women were older (41.6 ± 8.9 vs. 38.9±10.5 years, p <0.01) and were more likely to have anemia, hepatitis C virus (HCV) antibodies, and kidney dysfunction than HIV-uninfected women. HIV-infected women had significantly higher NT-pro-BNP levels (142.4 ± 524.8 vs. 73.6 ± 115.1 ng/liter, p = 0.01) and a higher prevalence of elevated NT-pro-BNP (12.1{\%} vs. 7.5{\%}; p= 0.08). In univariate analyses, elevated NT-pro-BNP was significantly associated with age, systolic BP, hypertension, anemia, triglyceride levels, kidney disease, and HCV seropositivity, but not HIV infection. In multivariate analysis, elevated NT-pro-BNP levels were significantly associated with anemia and kidney function, and had a borderline association with the presence of HCV antibodies. Among HIV-infected women, NT-pro-BNP levels were not independently associated with measures of severity of infection or with HAART use. Although HIV-infected women have higher NT-pro-BNP levels than HIV-uninfected women, the differences are due to non-HIV factors such as anemia, kidney disease, and HCV coinfection. These findings suggest that natriuretic peptide levels are a global marker of comorbidity in the setting of HIV infection.",
author = "Ather Mansoor and Keri Althoff and Gange, {Stephen J} and Kathryn Anastos and Jack Dehovitz and Howard Minkoff and Robert Kaplan and Susan Holman and Lazar, {Jason M.}",
year = "2009",
month = "10",
day = "1",
doi = "10.1089/aid.2009.0038",
language = "English (US)",
volume = "25",
pages = "997--1004",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women

AU - Mansoor, Ather

AU - Althoff, Keri

AU - Gange, Stephen J

AU - Anastos, Kathryn

AU - Dehovitz, Jack

AU - Minkoff, Howard

AU - Kaplan, Robert

AU - Holman, Susan

AU - Lazar, Jason M.

PY - 2009/10/1

Y1 - 2009/10/1

N2 - HIV infection is associated with left ventricular (LV) dysfunction and accelerated atherosclerosis. These conditions result in elevation of plasma natriuretic peptide (NP) levels. The present study compares N-terminal-pro-BNP (NT-pro-BNP) levels in HIV-infected and -uninfected women and identifies factors influencing NT-pro-BNP levels in HIV-infected women. A total of 454 HIV-infected and 200 HIV-uninfected participants from the Women's Interagency HIV Study (WIHS) had NT-pro-BNP determination. Elevated NT-pro-BNP level was defined using previously determined age stratified cut-off values of > 164 ng/liter (age 225 (age ≥ 60 years). HIV-infected women were older (41.6 ± 8.9 vs. 38.9±10.5 years, p <0.01) and were more likely to have anemia, hepatitis C virus (HCV) antibodies, and kidney dysfunction than HIV-uninfected women. HIV-infected women had significantly higher NT-pro-BNP levels (142.4 ± 524.8 vs. 73.6 ± 115.1 ng/liter, p = 0.01) and a higher prevalence of elevated NT-pro-BNP (12.1% vs. 7.5%; p= 0.08). In univariate analyses, elevated NT-pro-BNP was significantly associated with age, systolic BP, hypertension, anemia, triglyceride levels, kidney disease, and HCV seropositivity, but not HIV infection. In multivariate analysis, elevated NT-pro-BNP levels were significantly associated with anemia and kidney function, and had a borderline association with the presence of HCV antibodies. Among HIV-infected women, NT-pro-BNP levels were not independently associated with measures of severity of infection or with HAART use. Although HIV-infected women have higher NT-pro-BNP levels than HIV-uninfected women, the differences are due to non-HIV factors such as anemia, kidney disease, and HCV coinfection. These findings suggest that natriuretic peptide levels are a global marker of comorbidity in the setting of HIV infection.

AB - HIV infection is associated with left ventricular (LV) dysfunction and accelerated atherosclerosis. These conditions result in elevation of plasma natriuretic peptide (NP) levels. The present study compares N-terminal-pro-BNP (NT-pro-BNP) levels in HIV-infected and -uninfected women and identifies factors influencing NT-pro-BNP levels in HIV-infected women. A total of 454 HIV-infected and 200 HIV-uninfected participants from the Women's Interagency HIV Study (WIHS) had NT-pro-BNP determination. Elevated NT-pro-BNP level was defined using previously determined age stratified cut-off values of > 164 ng/liter (age 225 (age ≥ 60 years). HIV-infected women were older (41.6 ± 8.9 vs. 38.9±10.5 years, p <0.01) and were more likely to have anemia, hepatitis C virus (HCV) antibodies, and kidney dysfunction than HIV-uninfected women. HIV-infected women had significantly higher NT-pro-BNP levels (142.4 ± 524.8 vs. 73.6 ± 115.1 ng/liter, p = 0.01) and a higher prevalence of elevated NT-pro-BNP (12.1% vs. 7.5%; p= 0.08). In univariate analyses, elevated NT-pro-BNP was significantly associated with age, systolic BP, hypertension, anemia, triglyceride levels, kidney disease, and HCV seropositivity, but not HIV infection. In multivariate analysis, elevated NT-pro-BNP levels were significantly associated with anemia and kidney function, and had a borderline association with the presence of HCV antibodies. Among HIV-infected women, NT-pro-BNP levels were not independently associated with measures of severity of infection or with HAART use. Although HIV-infected women have higher NT-pro-BNP levels than HIV-uninfected women, the differences are due to non-HIV factors such as anemia, kidney disease, and HCV coinfection. These findings suggest that natriuretic peptide levels are a global marker of comorbidity in the setting of HIV infection.

UR - http://www.scopus.com/inward/record.url?scp=70449476946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449476946&partnerID=8YFLogxK

U2 - 10.1089/aid.2009.0038

DO - 10.1089/aid.2009.0038

M3 - Article

VL - 25

SP - 997

EP - 1004

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 10

ER -